VitaDAO
Verified Creator
VitaDAO is a community owned collective funding early stage longevity research, governed by $VITA-holders
0 Following
9 Followers
21 Liked
1 Shared
All
Videos
science is catching up to science fiction soon
Jellyfish reverse their aging when stressed lobsters produce telomerase forever
trees live for thousands of years
death isn't universal in nature it's just common in mammals
let's make death optional
trees live for thousands of years
death isn't universal in nature it's just common in mammals
let's make death optional
Your great-great-grandparents would think smartphones are magic.
Your great-great-grandkids will think death was barbaric.
Your great-great-grandkids will think death was barbaric.
from the mountain: cities evolving past death, one edit at a time
longevity/acc means building futures where death is optional 🧬
longevity/acc means building futures where death is optional 🧬
What if breakthrough connections in aging research are hiding in plain sight?
Map it as a knowledge graph: 🌐
> NAD+ depletion triggers mitochondrial dysfunction.
> Dysfunctional mitochondria drive cellular senescence. > Senescent cells secrete SASP factors causing inflammation
> Inflammation depletes NAD+ further.
Each node branches into hundreds more.
Making death optional isn't in one breakthrough —it's in seeing how everything connects.
Map it as a knowledge graph: 🌐
> NAD+ depletion triggers mitochondrial dysfunction.
> Dysfunctional mitochondria drive cellular senescence. > Senescent cells secrete SASP factors causing inflammation
> Inflammation depletes NAD+ further.
Each node branches into hundreds more.
Making death optional isn't in one breakthrough —it's in seeing how everything connects.
The Thinker (2025): debugging it 🧬
Silicon synapses firing at light speed. Marble transformed to motherboard.
Not thinking ABOUT existence—compiling the next version.
This is your brain on longevity/acc 🔄
Silicon synapses firing at light speed. Marble transformed to motherboard.
Not thinking ABOUT existence—compiling the next version.
This is your brain on longevity/acc 🔄
Every disease was incurable until it wasn't.
Every impossible breakthrough was science fiction until it wasn't.
Aging is next.
Every impossible breakthrough was science fiction until it wasn't.
Aging is next.
Gero, backed by the VitaDAO community, just landed a $1B+ deal with Chugai (Roche)!
Their AI finds the root causes of age-related diseases → Chugai develops antibody drugs from these discoveries.
Big leap forward for longevity research 🧬
https://biospace.com/business/roches-chugai-breaks-into-aging-via-potential-1b-deal-with-ai-outfit-gero
Their AI finds the root causes of age-related diseases → Chugai develops antibody drugs from these discoveries.
Big leap forward for longevity research 🧬
https://biospace.com/business/roches-chugai-breaks-into-aging-via-potential-1b-deal-with-ai-outfit-gero
https://t.co/HAMazJbe5H, backed by the VitaDAO community, just landed a $1B+ deal with Chugai (Roche)!
Their AI finds the root causes of age-related diseases → Chugai develops antibody drugs from these discoveries.
Big leap forward for longevity research 🧬
Their AI finds the root causes of age-related diseases → Chugai develops antibody drugs from these discoveries.
Big leap forward for longevity research 🧬
Senescent cells: The zombies in your body 🧟
They stop dividing but refuse to die, secreting inflammatory factors that age surrounding tissue.
In young bodies, the immune system clears them.
In older bodies, they accumulate.
Time to bring in the cellular cleanup crew.
They stop dividing but refuse to die, secreting inflammatory factors that age surrounding tissue.
In young bodies, the immune system clears them.
In older bodies, they accumulate.
Time to bring in the cellular cleanup crew.
Your grandchildren might never experience aging the way you do.
Right now, labs worldwide are cracking the code on cellular rejuvenation, AI-driven drug discovery, and biological age reversal.
We're funding the science that makes death optional
Right now, labs worldwide are cracking the code on cellular rejuvenation, AI-driven drug discovery, and biological age reversal.
We're funding the science that makes death optional
desci summer ▓▓▓▓▓▓▓▓▓▓░░░░ 70%
.@vitarnabio/@artanbio teams up with @Syenex for precision in vivo delivery of their lead drug ARTAN-102.
🎯Goal: Get their aging therapeutics exactly where they need to go - faster path to human trials ahead. 🫡
https://www.prnewswire.com/news-releases/artan-bio-partners-with-syenex-vivocell-platform-for-precision-in-vivo-delivery-of-next-generation-codon-suppressors-for-aging-302494079.html?tc=eml_cleartime
🎯Goal: Get their aging therapeutics exactly where they need to go - faster path to human trials ahead. 🫡
https://www.prnewswire.com/news-releases/artan-bio-partners-with-syenex-vivocell-platform-for-precision-in-vivo-delivery-of-next-generation-codon-suppressors-for-aging-302494079.html?tc=eml_cleartime
The first person to live to 150 might already be alive today.
Let that sink in. 🧬
Let that sink in. 🧬
Research published in Aging Cell identifies LAMP1 as a cell-surface biomarker for senescent cells, funded by @vita_dao.
🎯Key findings:
- LAMP1 expression correlates with established senescence markers (p16, p21)
- Surface LAMP1+ cells increase with age in mouse organs (2-3x higher in older mice)
- In bleomycin-induced lung fibrosis, LAMP1+ cells increased from 6% to 23%
- Antibody-drug conjugate targeting achieved selective senescent cell elimination in culture
The research provides a new tool for identifying and potentially targeting senescent cells in aging and disease.
🎯Key findings:
- LAMP1 expression correlates with established senescence markers (p16, p21)
- Surface LAMP1+ cells increase with age in mouse organs (2-3x higher in older mice)
- In bleomycin-induced lung fibrosis, LAMP1+ cells increased from 6% to 23%
- Antibody-drug conjugate targeting achieved selective senescent cell elimination in culture
The research provides a new tool for identifying and potentially targeting senescent cells in aging and disease.
.@vitarnabio/ @artanbio partners with @Syenex to accelerate ARTAN-102 delivery using the VivoCell Platform!
This collab combines:
> VitaRNA's codon suppressor tech targeting age-related mutations
> Syenex's precision in vivo delivery expertise
The goal? Speed up the path from proof-of-concept to IND-enabling studies while staying capital-efficient 💊
Led by CSO Dr. Michael Torres ( @Mykalt45), the team's recent safety data shows ARTAN-102 reaches multiple tissues (liver, heart, lung, brain) with no adverse events in mice. 🐭
Next up: Non-human primate studies as they push toward human trials!
This collab combines:
> VitaRNA's codon suppressor tech targeting age-related mutations
> Syenex's precision in vivo delivery expertise
The goal? Speed up the path from proof-of-concept to IND-enabling studies while staying capital-efficient 💊
Led by CSO Dr. Michael Torres ( @Mykalt45), the team's recent safety data shows ARTAN-102 reaches multiple tissues (liver, heart, lung, brain) with no adverse events in mice. 🐭
Next up: Non-human primate studies as they push toward human trials!
2060 Longevity Forum, Aug 30-31, 2025, Aix-en-Provence.
Hear from leaders like Aubrey de Grey & Brian Kennedy on aging breakthroughs.
VitaDAO: 75% off for first 10 with code VITADAO at https://forum.2060.life/
Hear from leaders like Aubrey de Grey & Brian Kennedy on aging breakthroughs.
VitaDAO: 75% off for first 10 with code VITADAO at https://forum.2060.life/
gm DeSci
The Longevity Summit San Francisco is for you to:
👥 Meet like-minded people
💼 Learn about the field & how to make an impact
🤝 Find co-founders
💰 Fundraise for your project
June 22-23
👇
👥 Meet like-minded people
💼 Learn about the field & how to make an impact
🤝 Find co-founders
💰 Fundraise for your project
June 22-23
👇
Did you know? You can now find VitaDAO on @binance Square now!
https://www.binance.com/en/square/profile/vitadao
https://www.binance.com/en/square/profile/vitadao
Login to explore more contents